Sourced from:Manufacturer Authorized Distributor
Quick Summary
Cibinqo 200mg Tablet
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹60938
MRP: ₹70382.81
(You Save ₹9444.81)
28 TABLET(s) IN A BOX
Cibinqo 200mg Tablet is a prescription medicine used to treat moderate to severe atopic dermatitis (eczema) in adults who have not responded adequately to other systemic treatments. It contains abrocitinib, a Janus kinase (JAK) inhibitor that works by blocking specific enzymes involved in inflammation, helping to reduce itching, redness, and skin irritation. Cibinqo 200mg Tablet should be taken under strict medical supervision as part of a comprehensive treatment plan.
Sourced from:Manufacturer Authorized Distributor
13% OFF
₹60938
MRP: ₹70,382.81
Inclusive of all taxes
13% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Jabryus 200mg Tablet
GLENMARK PHARMA...
₹ 8748.29/tablet
302% costlier
Introduction
Cibinqo 200mg Tablet, also known as Cibinqo tablet, contains the active ingredient Abrocitinib, a Janus kinase (JAK) inhibitor. Cibinqo uses include improving skin condition, reducing itchiness, and helping patients sleep better by relieving discomfort caused by itching. It also supports emotional well-being by improving symptoms of anxiety and depression often linked with atopic dermatitis.
Cibinqo for eczema (atopic dermatitis) is prescribed for patients with moderate to severe atopic dermatitis, a chronic skin condition that causes dry, itchy, and inflamed skin. If you’re wondering, how does Cibinqo work? — it blocks certain enzymes (JAK1) involved in the inflammation process, helping reduce redness, swelling, and itching.
Many patients look up the Cibinqo 200mg price before starting treatment. Your doctor may also recommend the Cibinqo 200mg tablet based on the severity of your condition and your overall health status.
Uses
- Treat moderate-to-severe atopic dermatitis in adults
How Cibinqo 200mg Tablet works
Cibinqo 200mg Tablet is a Janus kinase inhibitor that helps to reduce the activity of the enzyme Janus kinase, which is involved in inflammation. Therefore, it helps to improve the skin condition related to atopic dermatitis in patients.
Interaction of Cibinqo 200mg Tablet with other drugs
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Cibinqo 200mg Tablet and can cause undesirable side effects.
Storage conditions
- Store at 25°C
- Keep children away from the sight and reach of this medication.
How to take Cibinqo 200mg Tablet
Always use this medicine as exactly prescribed by your doctor. Depending on the condition being treated, your physician decides the dose, dosage, and frequency of this medicine. Do not chew, crush or dissolve the tablets. Swallow the tablets whole with water.
Safety Advice for Cibinqo 200mg Tablet
Breast Feeding
It is unknown whether Cibinqo 200mg Tablet is excreted in breast milk. So, before starting the treatment, inform your doctor if you are breastfeeding. Consult your doctor for more information.
Alcohol
It is unknown whether consuming alcohol while taking Cibinqo 200mg Tablet is safe. Please speak with your physician before using the medicine.
Liver
Inform your physician about any underlying liver disorders before taking Cibinqo 200mg Tablet, as this medicine may not be given to patients who have a severe liver disorder.
Lungs
It is unknown whether the Cibinqo 200mg Tablet is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Driving
It is unknown whether Cibinqo 200mg Tablet alters driving ability. However, if you experience side effects like tiredness or drowsiness, avoid driving and using machines.
Pregnancy
It is unknown whether the Cibinqo 200mg Tablet is harmful to the unborn baby. Notify your healthcare professional if you are pregnant planning to have a baby or think you might be pregnant.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Common
- Feeling sick in the stomach (nausea)
- Cold sores
- Vomiting
- Upper abdominal pain
- Dizziness
- Acne
- Increase the blood creatine phosphokinase enzyme level.
Expert Tips
-
Drink enough water to compensate for fluid loss during vomiting.
-
Avoid eating junk or oily foods, as they can worsen the adverse effects of the medicine.
-
Apply a cold compress to help reduce pain and inflammation caused by cold sores.
-
Inform your doctor if you are going for a blood test, as the medicine may interfere with the test results.
-
Lie down and rest for a few minutes if you feel dizzy until the dizziness passes.
FAQs about Cibinqo 200mg Tablet
Q1.
Can I take a Cibinqo 200mg Tablet if I have tuberculosis?
No, it is recommended to speak with your doctor if you have a tuberculosis infection. You can also speak with your doctor to perform a tuberculosis screening to ensure the safe use of the drug.
Q2.
Can I take a blood test while using the Cibinqo 200mg Tablet?
Consult your doctor if you are going for a blood test; the medicine can interfere with the results obtained by the patients. It may raise the creatine phosphokinase level in the blood.
Q3.
Is Cibinqo 200mg Tablet safe for elders?
Inform your doctor if you are a patient who is at the age of 65 years or above; it may increase the risk of infection, heart attack, and certain types of cancer in such patients.
Fact Box of Cibinqo 200mg Tablet
|
Molecule name |
Abrocitinib |
|
Therapeutic class |
Selective immunosuppressants |
|
Pharmacological class |
Tyrosine kinases inhibitor |
|
Indications |
Treat moderate-to-severe atopic dermatitis in adults |
References
Pfizer Manufacturing Deutschland GmbH, European Medicines Agency (EMA), [Revised on 18 July 2024] [Accessed on 21 May 2024], QRD Human Product Information Template (medicines.org.uk)
Sanofi-aventis,. US Food and Drug Administration, FDA [Revised on Jan 2022] [Accessed on 21st May 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213871s000lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Ishwarya R.
M.Sc.
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy
